Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price dropped 2.4% during trading on Friday . The stock traded as low as GBX 100 ($1.24) and last traded at GBX 102.50 ($1.27). Approximately 42,693 shares changed hands during trading, an increase of 2% from the average daily volume of 41,958 shares. The stock had previously closed at GBX 105 ($1.30).
Celadon Pharmaceuticals Price Performance
The company has a market cap of £65.82 million and a PE ratio of -788.46. The business’s 50 day moving average price is GBX 99.32 and its 200-day moving average price is GBX 101.60. The company has a quick ratio of 6.97, a current ratio of 1.86 and a debt-to-equity ratio of 153.26.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Are Penny Stocks a Good Fit for Your Portfolio?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What is the Euro STOXX 50 Index?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
